HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

5th Edition of Euro-Global Conference on Biotechnology and Bioengineering

September 18-20 | Hybrid Event

September 18-20, 2025 | London, UK

Gene Therapy

Gene Therapy

Gene Therapy is a promising field in biotechnology aimed at treating genetic disorders by introducing therapeutic genes into a patient's cells. This cutting-edge approach holds the potential to revolutionize medicine by addressing the root causes of diseases at the genetic level. One of the key strategies in gene therapy involves the use of viral vectors to deliver therapeutic genes into target cells. These vectors are modified viruses that are rendered harmless but retain their ability to infect cells and deliver genetic material. Once inside the cell, the therapeutic gene can either replace a defective gene or supplement its function, restoring normal cellular activity. However, challenges such as immune responses to the viral vectors and the risk of unintended genetic changes must be carefully addressed. Gene therapy has shown remarkable success in treating certain genetic disorders, such as severe combined immunodeficiency (SCID), hemophilia, and certain types of inherited blindness. Ongoing research aims to expand the application of gene therapy to a broader range of diseases, including cancer, neurodegenerative disorders, and cardiovascular diseases. The development of more precise gene editing techniques, such as CRISPR-Cas9, holds great promise for enhancing the effectiveness and safety of gene therapy. Despite the immense potential, gene therapy still faces regulatory hurdles and ethical considerations, particularly regarding the long-term effects and accessibility of treatment. Nevertheless, ongoing advancements in gene therapy continue to drive progress towards safer, more effective treatments for a wide range of genetic diseases, offering hope for patients and clinicians alike.

Committee Members
Speaker at Biotechnology and Bioengineering 2025 - Michele Mishto

Michele Mishto

Francis Crick Institute, United Kingdom
Speaker at Biotechnology and Bioengineering 2025 - Thomas J Webster

Thomas J Webster

Interstellar Therapeutics, United States
Speaker at Biotechnology and Bioengineering 2025 - Murray Moo Young

Murray Moo Young

University of Waterloo, Canada
ECBB 2025 Speakers
Speaker at Biotechnology and Bioengineering 2025 - Luis Jesus Villarreal Gomez

Luis Jesus Villarreal Gomez

Universidad Autonoma de Baja California, Mexico
Speaker at Biotechnology and Bioengineering 2025 - Assad Al Ammar

Assad Al Ammar

Specialty Enzymes and Probiotics, United States
Speaker at Biotechnology and Bioengineering 2025 - Tina Moller Tagmose

Tina Moller Tagmose

Novo Nordisk A/S, Denmark
Speaker at Biotechnology and Bioengineering 2025 - Yin Ying Ho

Yin Ying Ho

Agency for Science, Technology and Research (A*STAR), Singapore

Submit your abstract Today

Watsapp
a